The experts are prompting regulators at the US Food and Drug Administration (FDA) to have a broad "open-minded" perspective when it comes to regulating e-cigarettes.
The experts analysed much of the evidence published to date on e-cigarettes, and suggested that use of these products can lead to reduced cigarette smoking overall with a potential reduction in deaths from cigarette smoking.
"We're concerned the FDA, which has asserted its right to regulate e-cigarettes, will focus solely on the possibility that e-cigarettes and other vapour nicotine products might act as gateway to cigarette use," said David T Levy, professor at the Georgetown University in the US.
Experts, including those from Medical University of South Carolina in US, University of Waterloo in Canada, and Cancer Control Victoria in Australia said the 2014 Surgeon General's Report stated, "the burden of death and disease from tobacco in the US is overwhelmingly caused by cigarettes and other combusted tobacco products."
E-cigarettes may counteract those health risks and experts estimate that exclusive e-cigarette use is associated with about five per cent of the mortality risks of smoking, Levy said.
Levy and his colleagues reported research in the US, Canada and the UK, that shows cigarette smoking rates have fallen more in the last two years than they have in the previous four or five years and that this trend has coincided with the increase in e-cigarette use.
"While e-cigarettes may act as a gateway to smoking, much of the evidence indicates that e-cigarette use encourages cessation from cigarettes by those people who would have otherwise smoked with or without e-cigarettes," Levy said.
"We don't want to encourage e-cigarette use by youth and young adults who would not have otherwise smoked. However, the primary aim of tobacco control policy should be to discourage cigarette use while providing the means for smokers to more easily quit smoking, even if that means switching for some time to e-cigarettes rather than quitting all nicotine use," the experts wrote in the journal Addiction.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
